(Q53619286)

16 May 2018

title

Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. (English)

1 reference

16 May 2018

0 references

0 references

1 reference

5

Lytt I Gardner

1 reference

16 May 2018

Timothy P Flanigan

4

object named as

Timothy P Flanigan

1 reference

16 May 2018

Anne Rompalo

7

object named as

Anne M Rompalo

1 reference

16 May 2018

author name string

Rakhi Kohli

1

1 reference

16 May 2018

Yungtai Lo

2

1 reference

16 May 2018

Peter Homel

3

1 reference

16 May 2018

Andrea A Howard

6

1 reference

16 May 2018

Galina Moskaleva

8

1 reference

16 May 2018

Paula Schuman

9

1 reference

16 May 2018

Ellie E Schoenbaum

10

1 reference

16 May 2018

HER Study Group

11

1 reference

16 May 2018

language of work or name

English

0 references

publication date

25 May 2006

1 reference

16 May 2018

Clinical Infectious Diseases

published in

1 reference

16 May 2018

volume

43

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

90-98

1 reference

16 May 2018

Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients

cites work

1 reference

Global strategies to prevent bacterial pneumonia in adults with HIV disease

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Declining HIV/AIDS mortality in New York City.

21 January 2018

1 reference

Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy

21 January 2018

1 reference

HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy

21 January 2018

1 reference

Changing profiles of injecting drug users with AIDS in a Hispanic population

21 January 2018

1 reference

Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy.

21 January 2018

1 reference

Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group

21 January 2018

1 reference

Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease.

21 January 2018

1 reference

Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia, and death in persons with AIDS.

21 January 2018

1 reference

Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis

21 January 2018

1 reference

Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults.

21 January 2018

1 reference

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

21 January 2018

1 reference

Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy

21 January 2018

1 reference

The epidemiology of recurrent bacterial pneumonia in people with AIDS in Europe

21 January 2018

1 reference

Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women

21 January 2018

1 reference

Drug use patterns over time among HIV-seropositive and HIV-seronegative women: the HER study experience

21 January 2018

1 reference

Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.

21 January 2018

1 reference

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.

21 January 2018

1 reference

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

21 January 2018

1 reference

23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort

21 January 2018

1 reference

The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996

21 January 2018

1 reference

Pneumonia in HIV-infected patients in the HAART era: Incidence, risk, and impact of the pneumococcal vaccination

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/504871

1 reference

16 May 2018

1 reference

16 May 2018